SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending due to conflicting but significant news, with the successful unfolding of its large BlueBird 6 satellite marking a major technological de-risking, validating its direct-to-device capability. This positive development and the stock's inclusion in the MSCI World Index are being discussed alongside a proposed $1 billion convertible senior notes offering, prompting community debate over long-term growth versus immediate capital needs and potential dilution.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Applovin is actively discussed following a double beat on recent earnings with impressive revenue growth and an expanding Axon AI engine, yet the community is perplexed by the initial negative price action amidst broader software sector jitters, despite a prior short-seller retraction that de-risked the stock.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending amidst mixed investor reactions to its latest shareholder letter and Q4 earnings, which underscore ongoing cash burn and its pre-revenue status, fueling community frustration. Simultaneously, optimistic discussions revolve around the Eagle Line pilot production as a key step towards scalable solid-state battery commercialization through licensing and future OEM partnerships.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Oral VK2735 advancing to Phase 3 is driving conversation for Viking Therapeutics, with the community discussing this acceleration as a major validation and fueling speculation around potential partnerships or a buyout amidst positive broader market dynamics for legitimate GLP-1 players.

HubSpot, Inc. engages in cloud-based customer relationship management. Its platform includes marketing, sales, service, operations and content management system, as well as other tools, integrations and native payment solutions. It operates through the following geographical segments: Americas, Europe and Asia Pacific. The company was founded by Brian Patrick Halligan and Dharmesh Shah on April 4, 2005, and is headquartered in Cambridge, MA.

HubSpot Inc

HubSpot is trending after reporting strong earnings, raising its outlook, and announcing a $1 billion share repurchase program, yet the stock experienced a significant drop, fueling investor frustration and a community debate over whether "AI fears" are unfairly impacting SaaS valuations.

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Fastly is surging after reporting a substantial earnings beat and robust forward guidance, prompting community excitement about the company's turnaround and its positioning to benefit from increasing AI demand at the edge. Many are discussing a potential breakout and renewed growth for the stock, though some caution profit-taking after the significant price movement.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco is trending following an earnings beat and raised guidance, fueled by robust demand for AI infrastructure, prompting community discussion around the stock nearing its dot-com era highs and its valuation in the current tech cycle.

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.

NovoCure Ltd

NovoCure is trending following a recent FDA approval of its Optune Pax therapy for locally advanced pancreatic cancer, based on positive PANOVA-3 trial results demonstrating a statistically significant survival benefit. The community is actively debating the clinical significance of this survival extension for patients, while also considering the broader potential of its Tumor Treating Fields platform across various oncology indications amid past commercial challenges.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending due to its recent FDA approval of NEREUS for motion sickness and strong anticipation for the February PDUFA of Bysanti for bipolar I and schizophrenia. Despite a recent jet lag drug rejection, the community sees immense value in its Tradipitant program for GLP-1 induced nausea, driving significant buyout speculation and a belief the company is deeply undervalued.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Churchill Capital Corp X - Ordinary Shares - Class A

Churchill Capital Corp X 

Churchill Capital Corp X (CCCX) is heavily trending as its anticipated merger with quantum technology firm Infleqtion nears, driven by significant new contracts with NASA and the U.S. Department of Energy. The community is buzzing with comparisons to other quantum stocks, touting Infleqtion as a "criminally undervalued" leader with substantial long-term potential, while closely watching for a post-merger surge.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Indian ETFs Set to Soar After US Pledges to Cut Tariffs to 18%

Indian ETFs jump after the United States pledges to cut tariffs on Indian goods to 18%, boosting sentiment and sparking a sharp rally in local markets.

Is WisdomTree India Earnings ETF (EPI) a Strong ETF Right Now?

Rupee's Record Low Puts These 3 India ETFs in the Spotlight

Rupee's record slide to 92 per USD puts ETFs like EPI in focus as investors weigh currency risk against India's upgraded growth outlook.

India ETFs Offer Compelling Growth Upside: Is the Risk Worth Taking?

Despite tariff worries and equity outflows, India's growth story makes its ETFs a compelling play.

Here's Why 2026 Could Be a Breakout Year for India ETFs

With economic optimism rising and long-term drivers strengthening, these ETFs offer a smart way to tap the country's 2026 breakout potential.

4 India ETFs Under the Spotlight as RBI Cuts Interest Rate

India ETFs, like INDY and FLIN, draw fresh attention as the country's stock market rallies on the RBI's latest rate cut.  

Should You Add India ETFs to Your Portfolio Now?

With forecasts rising and growth outlook strengthening across the economy, India ETFs like INDA and EPI could be gearing up for a major run.

Goldman Sachs' Upgrade: A Signal to Invest in Indian ETFs?

Goldman Sachs turns bullish on India, forecasting a 14% Nifty 50 rise and renewed upside potential for Indian ETFs like INDY and EPI.   


The Geopolitical Windfall for Indian ETFs as Trump Hints at Tariff Cut 

Indian ETFs like INDA and FLIN gain spotlight as U.S.-India trade deal seems to near, which could slash tariffs and reignite investor confidence. 

WisdomTree Trust - WisdomTree India Earnings Fund

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $COIN earnings on Thursday?

EPI
WisdomTree Trust - WisdomTree India Earnings Fund

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest EPI News

EPIWisdomTree Trust - WisdomTree India Earnings Fund